[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353379-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353379-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-role-of-cancer-and-immunosuppression-in-pneumocystis-pneumonia-a-large-comprehensive-population-based-study-brief-report","The role of cancer and immunosuppression in pneumocystis pneumonia: a large comprehensive population-based study - Brief report","","Population-based data on drivers of immunosuppression in pneumocystis jirovecii pneumonia (PJP) for non-HIV patients are limited. This cohort study used German health insurance claims (2015–2023) to identify PJP episodes, comorbidities, immunocompromising conditions, and therapies via ICD-10-GM, ATC, and OPS coding. Among 922,200 individuals, 171 PJP episodes were analyzed with hospitalization and 30-day all-cause mortality. Immunosuppression strongly predicted all outcomes, with markedly elevated hazard ratios for HIV, systemic steroids, and hematologic cancers. Mortality was driven mainly by hematologic cancers and high-dose steroids.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-role-of-cancer-and-immunosuppression-in-pneumocystis-pneumonia-a-large-comprehensive-population-based-study-brief-report/353379/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-role-of-cancer-and-immunosuppression-in-pneumocystis-pneumonia-a-large-comprehensive-population-based-study-brief-report/353379.png","ImageObject",300,407,{"name":42,"@type":43},"dhado","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about pneumocystis pneumonia?","Question",{"text":63,"@type":64},"The study evaluates how cancer and immunosuppression influence the occurrence, hospitalization, and 30-day all-cause mortality of pneumocystis pneumonia in non-HIV patients.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were PJP episodes identified in the claims data?",{"text":68,"@type":64},"PJP was defined using hospitalization and ICD-10-GM coded diagnoses for B59/B48.5, sepsis combined with B59/B48.5, or ambulatory B59/B48.5 followed by a PJP-effective anti-infective prescription.",{"name":70,"@type":61,"acceptedAnswer":71},"Which immunosuppressive factors most strongly predicted outcomes?",{"text":72,"@type":64},"Immunosuppression predicted all outcomes strongly, especially HIV, systemic steroids (including high-dose levels), and hematologic cancers, which also drove mortality.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353379,1790543268,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":97,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Infection (2026) 54:2115–2119  \n[https://doi.org/10.1007/s15010-026-02802-1](https://doi.org/10.1007/s15010-026-02802-1)  \nBRIEF REPORT  \nThe role of cancer and immunosuppression in pneumocystis pneumonia: a large comprehensive population-based study  \nFabian Reichel1,2 · FalkoTesch3 · Saskia Berger3,4 · Martin Seifert3 · Dirk Koschel1,2,5 · Jochen Schmitt3 · Martin Kolditz1,2  \nReceived: 23 January 2026 / Accepted: 16 April 2026 / Published online: 6 May 2026 © The Author(s) 2026  \nAbstract  \nAlthough pneumocystis jirovecii pneumonia (PJP) in non-HIV patients is increasingly recognized, comprehensive data on immunosuppressive drivers remain limited. We conducted a population-based cohort study using a German health insurance’s claims data (2015–2023) . PJP, comorbidities, immunocompromising conditions and therapies were identified by means of ICD-10-GM-, ATC- and OPS-coded records. 922,200 individuals were assessed for PJP occurrence, hospitalization and 30-day all-cause mortality. An Andersen-Gill model adjusted for key covariates. We identified 171 PJP episodes, with hospitalization in 88.3% and mortality in 24.5% . Frequent immunocompromising causes were hematologic cancers (42.6%), immunosuppressants (28.7%) and steroids (28.7%) . Immunosuppression rather than typical CAP risk factors strongly predicted all outcomes (HR 49.9 [31.5–78.9]) . Robust associations with PJP occurred for HIV (HR 67.5 [19.4–235]), systemic steroids (> 20 mg prednisone daily equivalent (HR 26.2 [13.2–52.1])) and hematologic cancers (HR 8.5 [4.5–16.3]) . Mortality was driven by hematologic cancers (HR 13.9 [4.8–40.2]) and high-dose steroids (HR 8.6 [1.6–47.1]) . Malignancy-related immunosuppression and steroids critically affect PJP risk and prognosis.  \nKeywords Pneumocystis · PCP · PJP · Pneumonia · Immunosuppression · Steroids · Mortality  \nIntroduction  \nPneumocystis jirovecii pneumonia (PJP), an opportunistic lung infection, is generally recognized as an AIDS-defining disease in HIV patients. As incidence and mortality in patients suffering from HIV has consistently decreased  \n􀀍 Fabian Reichel [fabian.reichel@ukdd.de](fabian.reichel@ukdd.de)  \n1 Medical Department I, Division of Pneumology, University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Fetscherstr. 74, 01307 Dresden, Germany  \n2 East German Lung Center / Ostdeutsches Lungenzentrum Dresden-Coswig, Dresden, Germany  \n3 Center for Evidence-Based Healthcare, Faculty of Medicine, University Hospital Carl Gustav Carus at TUD Dresden University of Technology, Dresden, Germany  \n4 Hospital Pharmacy, University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany  \n5 Department of Internal Medicine and Pneumology, Lungenzentrum Coswig, Germany  \nin the past, it has become increasingly more prevalent in otherwise immunocompromised individuals [1–5] . Thus, detailed data on development and prognosis of PJP and specific risk factors associated with different conditions of immunosuppression such as cancer or -related therapy is urgently called for.  \nMethods  \nThe following report is a subgroup analysis of our previously published retrospective population-based cohort study on risk factors for CAP and its outcome with an extended observation period for PJP and particular consideration of malignancies and immunosuppression. Detailed methodology including the definitions of different causes of immunosuppression can be obtained from thereabouts [6] . This investigation was approved by the TUD Dresden University of Technology ethics committee (EK143052018) . German health insurance’s claims data from 2015 to 2023 was pseudonymously investigated. PJP was defined as hospitalization and an ICD-10-GM-coded main discharge diagnosis  \nof B59 (2015–2018) or B48.5 (2019–2023), a main discharge diagnosis of sepsis (A40.x-A41.x) combined with a secondary diagnosis of B59 or B48.5, or an ambulatory diagnosis of B59 or B48.5 followed by a prescription of a PJP-","cbCaib1E7NGpdFyF","https://ap.wps.com/l/cbCaib1E7NGpdFyF","pdf",1005664,"English","# Abstract\n# Introduction\n# Methods\n## Study design and data source\n## PJP and mortality definitions\n## Statistical analysis and covariates","[{\"question\":\"What question does the study address about pneumocystis pneumonia?\",\"answer\":\"The study evaluates how cancer and immunosuppression influence the occurrence, hospitalization, and 30-day all-cause mortality of pneumocystis pneumonia in non-HIV patients.\"},{\"question\":\"How were PJP episodes identified in the claims data?\",\"answer\":\"PJP was defined using hospitalization and ICD-10-GM coded diagnoses for B59/B48.5, sepsis combined with B59/B48.5, or ambulatory B59/B48.5 followed by a PJP-effective anti-infective prescription.\"},{\"question\":\"Which immunosuppressive factors most strongly predicted outcomes?\",\"answer\":\"Immunosuppression predicted all outcomes strongly, especially HIV, systemic steroids (including high-dose levels), and hematologic cancers, which also drove mortality.\"}]","The role of cancer and immunosuppression in pneumocystis pneumonia: a large comprehensive population-based study - Brief report | PDF",1790105004,13,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2be11e96a1701d2c935baf3836ce17bf.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b711561e2407cc6e5d72455236f4357.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/923e68738a17f627df999c20c0cfb7cc.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/826278e40061a01c51e05f83bad614bc.webp",980,1301]